OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 48 filers reported holding OVID THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $3,077,000 | -33.1% | 394,436 | -39.4% | 0.00% | -40.0% |
Q1 2018 | $4,600,000 | -19.4% | 650,656 | +12.6% | 0.01% | -16.7% |
Q4 2017 | $5,705,000 | -2.6% | 578,005 | -13.4% | 0.01% | 0.0% |
Q3 2017 | $5,858,000 | -13.1% | 667,466 | +2.7% | 0.01% | -14.3% |
Q2 2017 | $6,739,000 | – | 650,074 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,540,671 | $2,835,000 | 1.27% |
Madison Avenue Partners, LP | 1,394,022 | $2,565,000 | 0.55% |
BVF INC/IL | 6,851,051 | $12,606,000 | 0.52% |
CHI Advisors LLC | 864,822 | $1,591,000 | 0.43% |
Rubric Capital Management LP | 4,516,300 | $8,310,000 | 0.42% |
EcoR1 Capital, LLC | 6,117,400 | $11,256,000 | 0.33% |
Artal Group S.A. | 2,500,000 | $4,600,000 | 0.20% |
DCF Advisers, LLC | 162,701 | $299,000 | 0.19% |
Oasis Management Co Ltd. | 270,000 | $497,000 | 0.08% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 908,500 | $1,672,000 | 0.04% |